IDEXX Laboratories, Inc. (IDXX)
NASDAQ
Real-time Data
01:30 PM
Day's Range
506.1252 wk Range
500.61Overview - IDXX - IDEXX Laboratories, Inc.
Key Statistics
Valuation
Enterprise Value
41.68B
P/E (Trailing)
‪37.14‬
P/E (Forward)
‪30.93‬
PEG Ratio
‪2.15‬
Price / Sales (TTM)
‪8.95‬
Price / Book
‪25.32‬
EV / EBITDA
‪25.70‬
Profitability
Gross Margin
‪64.03%‬
Profit Margin
‪25.03%‬
Operating Margin
‪34.98%‬
Return on Assets
‪27.08%‬
Return on Equity
‪74.21%‬
Ownership
Shares Outstanding
78.87M
Float
78.49M
Short % of Shares Outstanding
‪2.78%‬
Held by Insiders
‪0.22%‬
Held by Institutions
‪96.72%‬
Price stats
Beta
‪1.53‬
50-Day Avg
‪544.22‬
200-Day Avg
‪588.86‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
13 analysts
Average price target
‪$ 698.92‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IDXX - IDEXX Laboratories, Inc.
Peers - IDXX - IDEXX Laboratories, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
Profile Summary - IDXX - IDEXX Laboratories, Inc.
About
IDEXX Laboratories, Inc. is a global diagnostics and software company focused on animal health, water quality, and agricultural testing. IDEXX Laboratories, Inc. develops and supplies in-clinic veterinary diagnostic instruments, consumable test kits, reference laboratory services, and practice management software that…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
